New

End Stage Renal Disease (ESRD) Drug Market

2021

End Stage Renal Disease (ESRD) Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders, Others); Indication (End Stage Renal Disease (ESRD) Induced Hyperparathyroidism, End Stage Renal Disease (ESRD)Induced Hyperphosphatemia, End Stage Renal Disease (ESRD) Induced Hyperkalaemia); Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), and geography

| Report Code: TIPRE00016858 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

End Stage Renal Disease (ESRD) Drug Market 2028 By Product Type, Indication, Distribution Channel, and geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Late-stage renal disease, also called end-stage kidney disease, occurs when chronic kidney disease (the gradual loss of kidney function) reaches an advanced state. In end-stage renal disease, kidneys are no longer able to work, as they should to meet the body's needs. At this advanced stage of kidney disease, the kidneys have lost nearly all their ability to do their job effectively, and eventually dialysis or a kidney transplant is needed to live.

MARKET DYNAMICS

Factors driving the growth of the end stage renal disease (ESRD) drug market are the high prevalence of diseases leading to chronic kidney diseases, coupled with favourable reimbursement policy for the end-stage kidney disease drugs. However, the delay in the diagnosis of chronic kidney disease is expected to hamper the growth of the market. Moreover, rising investments by major market players in end-stage kidney disease drugs is anticipated to boost the market growth.

MARKET SCOPE

The "End Stage Renal Disease (ESRD) Drug Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of end stage renal disease (ESRD) drug market with detailed market segmentation by product type, indication, and distribution channel. The end stage renal disease (ESRD) drug market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in end stage renal disease (ESRD) drug market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The end stage renal disease (ESRD) drug market is segmented on the basis of product type, indication, and distribution channel. Based on product type, the market is segmented as Calcimimetics, Vitamin D, Sterols, Potassium Binders, and Calcium-Based Phosphate Binders. On the basis of indication, the market is categorized as end stage renal disease (ESRD) induced hyperparathyroidism, end stage renal disease (ESRD) induced hyperphosphatemia, and end stage renal disease (ESRD) induced hyperkalaemia. On the basis of distribution channel, the market is categorized as hospital pharmacies, online pharmacies, and retail pharmacies

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the end stage renal disease (ESRD) drug market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The end stage renal disease (ESRD) drug market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting end stage renal disease (ESRD) drug market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the end stage renal disease (ESRD) drug market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the end stage renal disease (ESRD) drug market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from end stage renal disease (ESRD) drug market are anticipated to have lucrative growth opportunities in the future with the rising demand for end stage renal disease (ESRD) drugin the global market. Below mentioned is the list of few companies engaged in the end stage renal disease (ESRD) drug market .

The report also includes the profiles of key players in end stage renal disease (ESRD) drug market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  AbbVie Inc.
  •  Amgen
  •  AstraZeneca
  •  Sanofi
  •  Kyowa Kirin Co., Ltd.
  •  Takeda Pharmaceutical Company Limited
  •  Astellas Pharma Inc.
  •  Bayer AG
  •  Vifor Pharma Management Ltd.
  •  Akebia Drugs, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 End Stage Renal Disease (ESRD) Drug Market - By Product Type
1.3.2 End Stage Renal Disease (ESRD) Drug Market - By Indication
1.3.3 End Stage Renal Disease (ESRD) Drug Market - By Distribution Channel
1.3.4 End Stage Renal Disease (ESRD) Drug Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. END STAGE RENAL DISEASE (ESRD) DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. END STAGE RENAL DISEASE (ESRD) DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. END STAGE RENAL DISEASE (ESRD) DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. END STAGE RENAL DISEASE (ESRD) DRUG - GLOBAL MARKET OVERVIEW
6.2. END STAGE RENAL DISEASE (ESRD) DRUG - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. END STAGE RENAL DISEASE (ESRD) DRUG MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. CALCIMIMETICS
7.3.1. Overview
7.3.2. Calcimimetics Market Forecast and Analysis
7.4. VITAMIN D
7.4.1. Overview
7.4.2. Vitamin D Market Forecast and Analysis
7.5. STEROLS
7.5.1. Overview
7.5.2. Sterols Market Forecast and Analysis
7.6. POTASSIUM BINDERS
7.6.1. Overview
7.6.2. Potassium Binders Market Forecast and Analysis
7.7. CALCIUM-BASED PHOSPHATE BINDERS
7.7.1. Overview
7.7.2. Calcium-Based Phosphate Binders Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. END STAGE RENAL DISEASE (ESRD) DRUG MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. END STAGE RENAL DISEASE (ESRD) INDUCED HYPERPARATHYROIDISM
8.3.1. Overview
8.3.2. End Stage Renal Disease (ESRD) Induced Hyperparathyroidism Market Forecast and Analysis
8.4. END STAGE RENAL DISEASE (ESRD)INDUCED HYPERPHOSPHATEMIA
8.4.1. Overview
8.4.2. End Stage Renal Disease (ESRD)Induced Hyperphosphatemia Market Forecast and Analysis
8.5. END STAGE RENAL DISEASE (ESRD) INDUCED HYPERKALAEMIA
8.5.1. Overview
8.5.2. End Stage Renal Disease (ESRD) Induced Hyperkalaemia Market Forecast and Analysis
9. END STAGE RENAL DISEASE (ESRD) DRUG MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. ONLINE PHARMACIES
9.4.1. Overview
9.4.2. Online Pharmacies Market Forecast and Analysis
9.5. RETAIL PHARMACIES
9.5.1. Overview
9.5.2. Retail Pharmacies Market Forecast and Analysis
10. END STAGE RENAL DISEASE (ESRD) DRUG MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America End Stage Renal Disease (ESRD) Drug Market Overview
10.1.2 North America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis
10.1.3 North America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Product Type
10.1.4 North America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Indication
10.1.5 North America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Countries
10.1.6.1 United States End Stage Renal Disease (ESRD) Drug Market
10.1.6.1.1 United States End Stage Renal Disease (ESRD) Drug Market by Product Type
10.1.6.1.2 United States End Stage Renal Disease (ESRD) Drug Market by Indication
10.1.6.1.3 United States End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.1.6.2 Canada End Stage Renal Disease (ESRD) Drug Market
10.1.6.2.1 Canada End Stage Renal Disease (ESRD) Drug Market by Product Type
10.1.6.2.2 Canada End Stage Renal Disease (ESRD) Drug Market by Indication
10.1.6.2.3 Canada End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.1.6.3 Mexico End Stage Renal Disease (ESRD) Drug Market
10.1.6.3.1 Mexico End Stage Renal Disease (ESRD) Drug Market by Product Type
10.1.6.3.2 Mexico End Stage Renal Disease (ESRD) Drug Market by Indication
10.1.6.3.3 Mexico End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe End Stage Renal Disease (ESRD) Drug Market Overview
10.2.2 Europe End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis
10.2.3 Europe End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Product Type
10.2.4 Europe End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Indication
10.2.5 Europe End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Countries
10.2.6.1 Germany End Stage Renal Disease (ESRD) Drug Market
10.2.6.1.1 Germany End Stage Renal Disease (ESRD) Drug Market by Product Type
10.2.6.1.2 Germany End Stage Renal Disease (ESRD) Drug Market by Indication
10.2.6.1.3 Germany End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.2.6.2 France End Stage Renal Disease (ESRD) Drug Market
10.2.6.2.1 France End Stage Renal Disease (ESRD) Drug Market by Product Type
10.2.6.2.2 France End Stage Renal Disease (ESRD) Drug Market by Indication
10.2.6.2.3 France End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.2.6.3 Italy End Stage Renal Disease (ESRD) Drug Market
10.2.6.3.1 Italy End Stage Renal Disease (ESRD) Drug Market by Product Type
10.2.6.3.2 Italy End Stage Renal Disease (ESRD) Drug Market by Indication
10.2.6.3.3 Italy End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.2.6.4 Spain End Stage Renal Disease (ESRD) Drug Market
10.2.6.4.1 Spain End Stage Renal Disease (ESRD) Drug Market by Product Type
10.2.6.4.2 Spain End Stage Renal Disease (ESRD) Drug Market by Indication
10.2.6.4.3 Spain End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.2.6.5 United Kingdom End Stage Renal Disease (ESRD) Drug Market
10.2.6.5.1 United Kingdom End Stage Renal Disease (ESRD) Drug Market by Product Type
10.2.6.5.2 United Kingdom End Stage Renal Disease (ESRD) Drug Market by Indication
10.2.6.5.3 United Kingdom End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.2.6.6 Rest of Europe End Stage Renal Disease (ESRD) Drug Market
10.2.6.6.1 Rest of Europe End Stage Renal Disease (ESRD) Drug Market by Product Type
10.2.6.6.2 Rest of Europe End Stage Renal Disease (ESRD) Drug Market by Indication
10.2.6.6.3 Rest of Europe End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Overview
10.3.2 Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis
10.3.3 Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Countries
10.3.6.1 Australia End Stage Renal Disease (ESRD) Drug Market
10.3.6.1.1 Australia End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.1.2 Australia End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.1.3 Australia End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3.6.2 China End Stage Renal Disease (ESRD) Drug Market
10.3.6.2.1 China End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.2.2 China End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.2.3 China End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3.6.3 India End Stage Renal Disease (ESRD) Drug Market
10.3.6.3.1 India End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.3.2 India End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.3.3 India End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3.6.4 Japan End Stage Renal Disease (ESRD) Drug Market
10.3.6.4.1 Japan End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.4.2 Japan End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.4.3 Japan End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3.6.5 South Korea End Stage Renal Disease (ESRD) Drug Market
10.3.6.5.1 South Korea End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.5.2 South Korea End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.5.3 South Korea End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3.6.6 Indonesia End Stage Renal Disease (ESRD) Drug Market
10.3.6.6.1 Indonesia End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.6.2 Indonesia End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.6.3 Indonesia End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.3.6.7 Rest of Asia-Pacific End Stage Renal Disease (ESRD) Drug Market
10.3.6.7.1 Rest of Asia-Pacific End Stage Renal Disease (ESRD) Drug Market by Product Type
10.3.6.7.2 Rest of Asia-Pacific End Stage Renal Disease (ESRD) Drug Market by Indication
10.3.6.7.3 Rest of Asia-Pacific End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa End Stage Renal Disease (ESRD) Drug Market Overview
10.4.2 Middle East and Africa End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis
10.4.3 Middle East and Africa End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa End Stage Renal Disease (ESRD) Drug Market
10.4.6.1.1 South Africa End Stage Renal Disease (ESRD) Drug Market by Product Type
10.4.6.1.2 South Africa End Stage Renal Disease (ESRD) Drug Market by Indication
10.4.6.1.3 South Africa End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.4.6.2 Saudi Arabia End Stage Renal Disease (ESRD) Drug Market
10.4.6.2.1 Saudi Arabia End Stage Renal Disease (ESRD) Drug Market by Product Type
10.4.6.2.2 Saudi Arabia End Stage Renal Disease (ESRD) Drug Market by Indication
10.4.6.2.3 Saudi Arabia End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.4.6.3 U.A.E End Stage Renal Disease (ESRD) Drug Market
10.4.6.3.1 U.A.E End Stage Renal Disease (ESRD) Drug Market by Product Type
10.4.6.3.2 U.A.E End Stage Renal Disease (ESRD) Drug Market by Indication
10.4.6.3.3 U.A.E End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa End Stage Renal Disease (ESRD) Drug Market
10.4.6.4.1 Rest of Middle East and Africa End Stage Renal Disease (ESRD) Drug Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa End Stage Renal Disease (ESRD) Drug Market by Indication
10.4.6.4.3 Rest of Middle East and Africa End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America End Stage Renal Disease (ESRD) Drug Market Overview
10.5.2 South and Central America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis
10.5.3 South and Central America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Indication
10.5.5 South and Central America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America End Stage Renal Disease (ESRD) Drug Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil End Stage Renal Disease (ESRD) Drug Market
10.5.6.1.1 Brazil End Stage Renal Disease (ESRD) Drug Market by Product Type
10.5.6.1.2 Brazil End Stage Renal Disease (ESRD) Drug Market by Indication
10.5.6.1.3 Brazil End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.5.6.2 Argentina End Stage Renal Disease (ESRD) Drug Market
10.5.6.2.1 Argentina End Stage Renal Disease (ESRD) Drug Market by Product Type
10.5.6.2.2 Argentina End Stage Renal Disease (ESRD) Drug Market by Indication
10.5.6.2.3 Argentina End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
10.5.6.3 Rest of South and Central America End Stage Renal Disease (ESRD) Drug Market
10.5.6.3.1 Rest of South and Central America End Stage Renal Disease (ESRD) Drug Market by Product Type
10.5.6.3.2 Rest of South and Central America End Stage Renal Disease (ESRD) Drug Market by Indication
10.5.6.3.3 Rest of South and Central America End Stage Renal Disease (ESRD) Drug Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL END STAGE RENAL DISEASE (ESRD) DRUG MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. END STAGE RENAL DISEASE (ESRD) DRUG MARKET, KEY COMPANY PROFILES
13.1. ABBVIE INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AMGEN
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ASTRAZENECA
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. SANOFI
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. KYOWA KIRIN CO., LTD.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. TAKEDA PHARMACEUTICAL COMPANY LIMITED
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ASTELLAS PHARMA INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BAYER AG
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. VIFOR PHARMA MANAGEMENT LTD.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. AKEBIA DRUGS, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. AbbVie Inc.
2. Amgen
3. AstraZeneca
4. Sanofi
5. Kyowa Kirin Co., Ltd.
6. Takeda Pharmaceutical Company Limited
7. Astellas Pharma Inc.
8. Bayer AG
9. Vifor Pharma Management Ltd.
10. Akebia Drugs, Inc.
TIPRE00016858
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.